Basic Characteristics, Status, and Challenges of Integrative Oncology in China

Yang, Geliang; Zhang, Huiqing; Xu, Yun; Zhao, Aizhi; Shu, Ping; Wang, Wei; Zhang, Haibo; Wang, Tingting; Yang, Yufei

doi:10.1177/15347354211063504

Cited by 4 publications

(8 citation statements)

References 16 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The full text of one study could not be retrieved, and 62 full-text studies failed to meet the criteria and so were eliminated. The remaining 28 studies met our criteria and had been published between 1998 and 202123–50 ((online supplemental table S1), (online supplemental file 2). Twenty-five were single-site studies, mainly from Europe (n = 8), North America (n = 7) and Oceania (n = 6).…”

Section: Resultsmentioning

confidence: 99%

Integrative oncology in cancer care – implementation factors: mixed-methods systematic review

Kwong

et al. 2023

BMJ Support Palliat Care

View full text Add to dashboard Cite

BackgroundIntegrative oncology (IO) appears to be beneficial to patients with cancer, but its implementation remains a challenge. Guided by the Theoretical Domains Framework (TDF) and the Capability–Opportunity–Motivation–Behaviour (COM-B) model, this systematic review identified the barriers to and facilitators of IO implementation in conventional cancer care settings.MethodsWe searched eight electronic databases from their inception until February 2022 for qualitative, quantitative or mixed-methods empirical studies reporting the implementation outcomes for IO services. Critical appraisal approach was tailored according to study types. The identified implementation barriers and facilitators were mapped onto TDF domains and the COM-B model, and subsequently onto the behavioural change wheel (BCW) for formulating behavioural change interventions.ResultsWe included 28 studies (11 qualitative, 6 quantitative, 9 mixed-methods and 2 Delphi studies) of satisfied methodological quality. The main implementation barriers were the lack of IO knowledge, the absence of funding and healthcare professionals’ low level of IO receptiveness. The key implementation facilitators were the dissemination of evidence on IO clinical benefits, the equipping of professionals with IO service delivery skills and the provision of a supportive organisational climate.ConclusionMultifaceted implementation strategies are needed to address the determinants influencing IO service delivery. Based on our BCW-based analysis of the included studies, the keybehavioural change techniquesare: (1) educating healthcare professionals about the value and application of traditional and complementary medicine; (2) ensuring access to actionable clinical evidence on IO effectiveness and safety and (3) designing guidelines on communicating traditional and complementary medicine interventions with patients and caregivers for biomedically trained doctors and nurses.

show abstract

Section: Resultsmentioning

confidence: 99%

Integrative oncology in cancer care – implementation factors: mixed-methods systematic review

Kwong

et al. 2023

BMJ Support Palliat Care

View full text Add to dashboard Cite

show abstract

“…They found only half of oncologists agreed that CAMs had a role in cancer medicine. Conversely, Yang et al 12 . who surveyed oncologists in China, reported that 95.3% of oncologists were positive toward integrative oncology or the incorporation of CAMs into conventional treatment.…”

Section: Discussionmentioning

confidence: 98%

“…They found only half of oncologists agreed that CAMs had a role in cancer medicine. Conversely, Yang et al 12 who surveyed oncologists in China, reported that 95.3% of oncologists were positive toward integrative oncology or the incorporation of CAMs into conventional treatment. It should be noted, however, that over half of the respondents of this survey identified as integrative physicians, which may have influenced this outcome.…”

Section: Influence Of Knowledge On Attitudesmentioning

confidence: 99%

“…Additionally, prior individual studies in the last decade have either combined professions and assessed their KAPs as a group 10 or focussed on the KAPs of one particular profession 8,11,12 . The only study identified to assess and contrast the KAPs of different health professionals was by Stub et al 13 .…”

Section: Introductionmentioning

confidence: 99%

“…8,9 Additionally, prior individual studies in the last decade have either combined professions and assessed their KAPs as a group 10 or focussed on the KAPs of one particular profession. 8,11,12 The only study identified to assess and contrast the KAPs of different health professionals was by Stub et al 13 published in 2018, which compared the KAPs of Norwegian physicians, nurses, and CAM practitioners regarding CAM use in oncology. This study found that doctors and nurses with no formal CAM training were generally concerned about the safety of combining CAMs with conventional cancer therapy as well as being hesitant toward their patients' use of CAMs or having discussions regarding CAMs.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Knowledge, attitudes, and practices of Australian oncology health professionals on complementary medicines

Keene

Heslop

Sabesan

et al. 2022

Pharmacy Practice and Res

View full text Add to dashboard Cite

Background: Approximately half of people with cancer are using complementary and alternative medicine (CAM), presenting safety concerns due to potential interactions with conventional cancer treatment. Oncology staff have a role to play in ensuring the safe use of CAMs and so, this study examined their knowledge, attitudes, and practices regarding CAMs. Aim: This study aimed to assess the knowledge, attitudes, and practices of Australian doctors, nurses, and pharmacists regarding CAM use in oncology. Method: Members of three national oncology professional associations took part in an online questionnaire, which determined their knowledge, attitudes, and practices regarding CAM. Results: Ninety-nine completed surveys were obtained from nine doctors, 70 nurses, and 20 pharmacists. Most respondents (68.4%) felt that they did not have adequate knowledge of CAMs to respond to patients' questions. Assessment of attitudes found respondents generally believed that CAMs have a complementary role in oncology but indicated their concerns for the safety of patients. Respondents indicated in practice they would discuss CAMs with less than half of patients (40.6%), with a lack of scientific data and guidelines for CAM use presenting significant barriers to these discussions. Conclusion: Our study suggests that oncology health professionals' knowledge of CAMs potentially leads to a lack of confidence in providing advice to patients and concerns for patient safety. This impacts their discussion of CAMs and lack of disclosure from patients about their use of CAMs. Education on CAMs in oncology would assist in increasing professionals' confidence in discussing these therapies, leading to increased patient disclosure of CAMs and safer treatment decision making for people with cancer.

show abstract

Characteristics and Challenges of Providing Acupuncture and Chinese Herbal Medicine in Oncology Treatment: Report of Survey Data and Experience of Five Unique Clinical Settings

Veleber,

Cohen,

Weitzman

et al. 2024

Integr Cancer Ther

View full text Add to dashboard Cite

Acupuncture is an integrative therapy with strong evidence to support its use in the oncology setting, yet barriers exist for implementation into conventional medical clinics. Though acupuncture is recommended in clinical practice guidelines for oncology, there is little data in the literature showing how acupuncture and other related therapies, including herbal medicine are successfully implemented in some oncology clinics, while others experience barriers to care. To characterize the current use of acupuncture (ACU) and herbal medicine (HM) in oncology clinics, we collected general demographic and usage data from 5 example clinics. In addition, to better understand the barriers faced by ACU and HM clinics in implementing acupuncture as a treatment modality, a survey was deployed to 2320 members of the Society for Integrative Oncology. This article examines the characteristics of oncology settings around the world, and shares data from the survey on the use of these therapies in the field of oncology. The primary barrier to acupuncture care, as reported by providers, was cost. With just under 70% of the oncologists reporting it as the most important obstacle. Additional barriers to implementation included concerns about competency and training, accessibility and safety of herbal medicine during treatment. Though acupuncture is being incorporated into more conventional oncology settings, organized strategies for implementation involving payers and policymakers is needed.

show abstract

Basic Characteristics, Status, and Challenges of Integrative Oncology in China

Cited by 4 publications

References 16 publications

Integrative oncology in cancer care – implementation factors: mixed-methods systematic review

Integrative oncology in cancer care – implementation factors: mixed-methods systematic review

Knowledge, attitudes, and practices of Australian oncology health professionals on complementary medicines

Characteristics and Challenges of Providing Acupuncture and Chinese Herbal Medicine in Oncology Treatment: Report of Survey Data and Experience of Five Unique Clinical Settings

Contact Info

Product

Resources

About